Boothbay Fund Management’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Hold |
189,899
| – | – | ﹤0.01% | 1066 |
|
|
2025
Q1 | $176K | Hold |
189,899
| – | – | ﹤0.01% | 1020 |
|
|
2024
Q4 | $228K | Hold |
189,899
| – | – | 0.01% | 1014 |
|
|
2024
Q3 | $220K | Hold |
189,899
| – | – | 0.01% | 1189 |
|
|
2024
Q2 | $199K | Hold |
189,899
| – | – | ﹤0.01% | 1138 |
|
|
2024
Q1 | $235K | Hold |
189,899
| – | – | ﹤0.01% | 1121 |
|
|
2023
Q4 | $211K | Buy |
+189,899
| New | +$211K | 0.01% | 1159 |
|
|
2023
Q3 | – | Sell |
-201,800
| Closed | -$2.19M | – | 1605 |
|
|
2023
Q2 | $2.19M | Hold |
201,800
| – | – | 0.05% | 410 |
|
|
2023
Q1 | $2.14M | Hold |
201,800
| – | – | 0.04% | 526 |
|
|
2022
Q4 | $2.08M | Hold |
201,800
| – | – | 0.05% | 480 |
|
|
2022
Q3 | $2.03M | Hold |
201,800
| – | – | 0.05% | 487 |
|
|
2022
Q2 | $2.02M | Hold |
201,800
| – | – | 0.05% | 482 |
|
|
2022
Q1 | $2.02M | Hold |
201,800
| – | – | 0.05% | 484 |
|
|
2021
Q4 | $2M | Buy |
201,800
+6,800
| +3% | +$67.4K | 0.05% | 404 |
|
|
2021
Q3 | $1.93M | Buy |
+195,000
| New | +$1.93M | 0.05% | 364 |
|